$45.62
-0.31 (-0.67%)
AstraZeneca plc (ADR) (AZN)
CAPS Rating:
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
RSS Headlines
Fool UK
Recs
Drug co, so a nice defensive stock (P/E is only 8) with a huge dividend yield (about 8%). I think the run-up recently was nice in the broader market, but stocks will go back down in the near future (I'm guessing about a 10% - 15% drop from current levels). In the meantime, AZN should hold steady (or go up as a defensive play). In the meanwhile you can collect on the dividend which is actually funded from operating cash (not borrowings like a lot of other companies recently). 3 thumbs up out of 3 (so much so, that I bought some shares today after selling my E*Trade stock that had a nice run recently).
AZN reported earnings today and they were very solid... actually beating analysts expectations, so what happens? The stock price drops b/c they still were being cautiously optimistic. I think this is time to buy a few more shares... I think these guys are sandbagging.
Is there something wrong with the pipeline at AZN? Why don't people appreciate the steady growth in shareholder equity and the gigantic free cash flow? OK, so AZN over paid for MedImmune, but that's in the past. The fundamentals still look strong. Why not pick up this stock at current levels? I just don't get people.
Ugh, I sold my position in this stock to invest in oil (ATW). While ATW has done ok, AZN finally started taking off (up 20% since I sold my position about 2 weeks ago). It takes months to go up 15%, and then the minute I sell, bam!
That's what I get for trying to time the market.
Still like this company, which is why I kept my pick here.